Home › Companies › Evolus, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Evolus, Inc.’s Form 8-K, filed June 12, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 11, 2026: 4 items on Evolus, Inc.’s Form 8-K, filed June 12, 2026: 2 elected · 2 approved.
Significant dissent: 1 director (46.9% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Nantahala Capital (13F, 9.4%, as of September 30, 2026)
Explore Evolus, Inc. in the interactive database Compare manager voting policies
These tallies are Evolus, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Brady Stewart | 38,479,626 | -- | -- | 1,662,228 | 11,183,774 | 96% | Elected | — |
| Elect Director: Vikram Malik | 21,310,653 | -- | -- | 18,831,201 | 11,183,774 | 53.1% | Elected | — |
| 2. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 | 51,230,324 | 63,992 | 18,696 | -- | -- | 99.9% | Approved | — |
| 3. The compensation of the Company's named executive officers | 39,350,651 | 336,958 | 441,629 | -- | 11,183,774 | 99.2% | Approved | — |
Source: Evolus, Inc., Form 8-K, filed with the SEC on June 12, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
161 asset managers disclosed a vote on at least one Evolus, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Class II directors for a three-year term: Brady Stewart
Evolus, Inc.’s own tally for this item (“Elect Director: Brady Stewart”): 38,479,626 for, 1,662,228 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The results for each matter voted on by the stockholders at the Annual Meeting were as follows: Proposal 1 : The stockholders of the Company elected each of Brady Stewart and Vikram Malik as Class II directors for a three-year term ending at the Annual Meeting of Stockholders to be held in 2029 and…”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 7,344,432 for, 159,305 withheld, 14,894 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,922,229 | 0 | 6 | 0 | For |
| BlackRock | 2,025,176 | 0 | 0 | 0 | For |
| Fidelity | 1,165,491 | 0 | 0 | 576 | For |
| Charles Schwab | 515,944 | 0 | 0 | 0 | For |
| Equitable | 82,988 | 0 | 0 | 37,060 | Mixed |
| CLEARWATER INVESTMENT TRUST | 115,686 | 0 | 0 | 0 | For |
| Goldman Sachs | 88,220 | 0 | 0 | 0 | For |
| TIAA | 88,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 86,490 | 0 | 0 | 0 | For |
| Russell Investments | 60,884 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 0 | 0 | 40,300 | Withhold |
| Lincoln Financial | 35,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 33,472 | 0 | 0 | 0 | For |
| Northern Trust | 28,512 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 27,594 | Withhold |
| Global X | 26,590 | 0 | 0 | 0 | For |
| Pacific Life | 16,510 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 14,888 | 0 | Abstain |
| Nationwide | 14,386 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 11,142 | Withhold |
| SEI | 11,000 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,044 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 9,541 | Withhold |
| DWS | 0 | 0 | 0 | 7,713 | Withhold |
| Brighthouse | 0 | 0 | 0 | 7,670 | Withhold |
Showing the 25 largest of 39 asset managers. All 39 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
53.1% Majority: yes · of votes cast
Description as filed by funds: Election of Class II directors for a three-year term: Vikram Malik
Evolus, Inc.’s own tally for this item (“Elect Director: Vikram Malik”): 21,310,653 for, 18,831,201 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The results for each matter voted on by the stockholders at the Annual Meeting were as follows: Proposal 1 : The stockholders of the Company elected each of Brady Stewart and Vikram Malik as Class II directors for a three-year term ending at the Annual Meeting of Stockholders to be held in 2029 and…”
Support: 53.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 7,306,799 for, 196,877 withheld, 14,956 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,913,388 | 0 | 68 | 8,780 | For |
| BlackRock | 2,025,176 | 0 | 0 | 0 | For |
| Fidelity | 1,165,491 | 0 | 0 | 576 | For |
| Charles Schwab | 515,944 | 0 | 0 | 0 | For |
| Equitable | 82,988 | 0 | 0 | 37,060 | Mixed |
| CLEARWATER INVESTMENT TRUST | 115,686 | 0 | 0 | 0 | For |
| Goldman Sachs | 88,220 | 0 | 0 | 0 | For |
| TIAA | 88,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 86,490 | 0 | 0 | 0 | For |
| Russell Investments | 60,884 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 0 | 0 | 40,300 | Withhold |
| Lincoln Financial | 35,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 33,472 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 28,512 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 27,594 | Withhold |
| Global X | 26,590 | 0 | 0 | 0 | For |
| Pacific Life | 16,510 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 14,888 | 0 | Abstain |
| Nationwide | 14,386 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 11,142 | Withhold |
| SEI | 11,000 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,044 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 9,541 | Withhold |
| DWS | 0 | 0 | 0 | 7,713 | Withhold |
| Brighthouse | 0 | 0 | 0 | 7,670 | Withhold |
Showing the 25 largest of 39 asset managers. All 39 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.2% Approved · of votes cast
Prior year: 96.7% for (June 5, 2025 meeting) ▲ 2.5 pts
Description as filed by funds: APPROVAL OF, ON AN ADVISORY BASIS, THE COMPENSATION OF EVOLUS' NAMED EXECUTIVE OFFICERS.
Evolus, Inc.’s own tally for this item (“3. The compensation of the Company's named executive officers”): 39,350,651 for, 336,958 against — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 : The stockholders of the Company approved, on an advisory basis, the compensation of the Company's named executive officers.”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Evolus, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Say on Pay” (2 managers, 634 against).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,922,232 | 1 | 1 | 0 | For |
| BlackRock | 2,025,176 | 0 | 0 | 0 | For |
| Fidelity | 1,166,067 | 0 | 0 | 0 | For |
| Charles Schwab | 515,944 | 0 | 0 | 0 | For |
| Equitable | 120,048 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 115,686 | 0 | 0 | 0 | For |
| Goldman Sachs | 88,220 | 0 | 0 | 0 | For |
| TIAA | 88,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 86,490 | 0 | 0 | 0 | For |
| Russell Investments | 60,884 | 0 | 0 | 0 | For |
| Capitol Series Trust | 40,300 | 0 | 0 | 0 | For |
| Lincoln Financial | 35,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 33,472 | 0 | 0 | 0 | For |
| Northern Trust | 28,512 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 27,594 | 0 | 0 | 0 | For |
| Global X | 26,590 | 0 | 0 | 0 | For |
| Pacific Life | 16,510 | 0 | 0 | 0 | For |
| John Hancock | 14,888 | 0 | 0 | 0 | For |
| Nationwide | 14,386 | 0 | 0 | 0 | For |
| ProShares | 11,142 | 0 | 0 | 0 | For |
| SEI | 11,000 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,044 | 0 | 0 | 0 | For |
| Voya | 9,541 | 0 | 0 | 0 | For |
| DWS | 7,713 | 0 | 0 | 0 | For |
| Brighthouse | 7,670 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 7,518,549 for, 80 against, 1 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 4,769,613 | 0 | 0 | 0 | For |
| Frazier Life Sciences Management, L.P. | 2,630,665 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 2,245,360 | 0 | 0 | 0 | For |
| Stonepine Capital Management, LLC | 1,759,091 | 0 | 0 | 0 | For |
| BlackRock | 1,700,546 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,385,091 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 1,279,253 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 1,129,279 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,055,473 | 0 | 0 | 0 | For |
| State Street | 837,835 | 2,260 | 0 | 0 | For |
| Invesco | 808,821 | 0 | 0 | 0 | For |
| PINNACLE ASSOCIATES LTD | 782,489 | 0 | 0 | 0 | For |
| AWH Capital, L.P. | 625,000 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 565,888 | 0 | 0 | 0 | For |
| Charles Schwab | 516,278 | 0 | 0 | 0 | For |
| Vanguard | 453,662 | 0 | 0 | 0 | For |
| Northern Trust | 354,418 | 2,659 | 0 | 0 | For |
| T. Rowe Price | 276,105 | 0 | 0 | 0 | For |
| DE Shaw | 202,566 | 0 | 0 | 0 | For |
| National Philanthropic Trust | 0 | 0 | 0 | 0 | Not Voted |
| Citadel | 196,912 | 0 | 0 | 0 | For |
| AMERICAN ASSETS INC | 150,000 | 0 | 0 | 0 | For |
| Goldman Sachs | 146,575 | 0 | 0 | 0 | For |
| Nuveen | 112,022 | 0 | 0 | 0 | For |
| Knott David M Jr | 99,338 | 0 | 0 | 0 | For |
Institutional-manager reports, all 133 managers: 24,965,494 for, 70,212 against, 1,000 abstained, 201,930 not voted. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Prior year: 99.6% for (June 5, 2025 meeting) ▲ 0.3 pts
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS EVOLUS' INDEPENDENT AUDITOR FOR THE YEAR ENDING DECEMBER 31, 2026.
Evolus, Inc.’s own tally for this item (“2. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 51,230,324 for, 63,992 against — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 : The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 7,512,433 for, 6,199 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,916,317 | 5,919 | 0 | 0 | For |
| BlackRock | 2,025,176 | 0 | 0 | 0 | For |
| Fidelity | 1,166,067 | 0 | 0 | 0 | For |
| Charles Schwab | 515,944 | 0 | 0 | 0 | For |
| Equitable | 120,048 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 115,686 | 0 | 0 | 0 | For |
| Goldman Sachs | 88,220 | 0 | 0 | 0 | For |
| TIAA | 88,006 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 86,490 | 0 | 0 | 0 | For |
| Russell Investments | 60,884 | 0 | 0 | 0 | For |
| Capitol Series Trust | 40,300 | 0 | 0 | 0 | For |
| Lincoln Financial | 35,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 33,472 | 0 | 0 | 0 | For |
| Northern Trust | 28,512 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 27,594 | 0 | 0 | 0 | For |
| Global X | 26,590 | 0 | 0 | 0 | For |
| Pacific Life | 16,510 | 0 | 0 | 0 | For |
| John Hancock | 14,888 | 0 | 0 | 0 | For |
| Nationwide | 14,386 | 0 | 0 | 0 | For |
| ProShares | 11,142 | 0 | 0 | 0 | For |
| SEI | 11,000 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,044 | 0 | 0 | 0 | For |
| Voya | 9,541 | 0 | 0 | 0 | For |
| DWS | 7,713 | 0 | 0 | 0 | For |
| Brighthouse | 7,670 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. All 39 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 65,839,803 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.44% |
| 2 | BlackRock | 3.08% |
| 3 | Fidelity | 1.77% |
| 4 | Charles Schwab | 0.78% |
| 5 | Equitable | 0.18% |
| 6 | CLEARWATER INVESTMENT TRUST | 0.18% |
| 7 | Goldman Sachs | 0.13% |
| 8 | TIAA | 0.13% |
| 9 | QUANTITATIVE MASTER SERIES LLC | 0.13% |
| 10 | Russell Investments | 0.09% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Nantahala Capital Management, LLC | 7.24% |
| 2 | Frazier Life Sciences Management, L.P. | 4.00% |
| 3 | Soleus Capital Management, L.P. | 3.41% |
| 4 | Stonepine Capital Management, LLC | 2.67% |
| 5 | BlackRock | 2.58% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.10% |
| 7 | PERCEPTIVE ADVISORS LLC | 1.94% |
| 8 | BRAIDWELL LP | 1.72% |
| 9 | RICE HALL JAMES & ASSOCIATES, LLC | 1.60% |
| 10 | State Street | 1.28% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Timothy P. Lynch | 6,425,726 | 9.76% | Schedule 13G, filed February 17, 2026 |
| BlackRock | 4,290,383 | 6.52% | Form 13F, quarter ended March 31, 2026 |
| Soleus Capital Master Fund, L.P. | 3,480,000 | 5.29% | Schedule 13G, filed August 31, 2026 |
| Vanguard Group | 3,341,804 | 5.08% | Form 13F, quarter ended March 31, 2026 |
| Millennium Management | 1,461,159 | 2.22% | Form 13F, quarter ended March 31, 2026 |
| State Street | 1,320,790 | 2.01% | Form 13F, quarter ended March 31, 2026 |
| Goldman Sachs | 1,086,398 | 1.65% | Form 13F, quarter ended March 31, 2026 |
| Citadel Advisors | 787,329 | 1.20% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 730,665 | 1.11% | Form 13F, quarter ended March 31, 2026 |
| D.E. Shaw | 559,050 | 0.85% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 65,839,803 shares outstanding, as reported by Evolus, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Evolus, Inc.'s shareholder meeting held June 11, 2026, in the 2025-2026 proxy season, 161 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 618 separate fund positions. On the most widely held item on that ballot — APPROVAL OF, ON AN ADVISORY BASIS, THE COMPENSATION OF EVOLUS' NAMED EXECUTIVE OFFICERS. — Evolus, Inc.'s filing reports the proposal as approved, with 99.2% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Evolus, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Evolus, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Evolus, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Evolus (EOLS) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/evolus-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.